Making
Hope Real.
Making
Hope Real.
The vision of the Snowdome Foundation is to ensure every Australian blood cancer
patient has the best opportunity for a cure, and this starts with a correct diagnosis.
We collaborate with world-leading Australian and international blood cancer researchers
to accelerate new therapies and bring next-generation treatments to patients, faster.
We are the leading not-for-profit organisation focused exclusively on raising funds to
support translational research and clinical trials that will accelerate new treatments
(and cures) to help Australian blood cancer patients live longer, better lives.
Over $53 million has been committed to blood cancer research since 2010.
67 research projects funded enabling 98 research positions.
Over 6,200 genomic tests completed at the Wilson Centre for Blood Cancer Genomics.
Enabled 1,817 patients to participate in clinical trials supported by Snowdome.
Latest News
Funding Extension Announced for World-First B-cell Lymphoma Research
Snowdome Foundation has committed to a further two years of funding for world-first research led by Dr Adrian Minson at the Peter MacCallum Cancer Centre, aimed at optimising immunotherapy for aggressive B-cell lymphomas.
Read more
Research Update: Inaugural Snowdome Haematology Fellowship
Research undertaken as part of the inaugural Snowdome Haematology Fellowship, awarded to Dr Josh Tobin in 2022 is set to have a transformative impact on frontline treatment for follicular lymphoma, offering more personalised, safer and effective treatment.
Read more
2025 Cannon Family Travel Grant Awardees
The Snowdome Foundation congratulates Dr Paniz Tavakoli and Dr Helen Cashman who have been announced as the 2025 Cannon Family Travel Grant recipients.
Read moreSign up for our newsletter
Sign up to our quarterly newsletter to read
all the latest news from Snowdome.
